Display options
Cite
Huang R, Okuno H, Takasu M, et al. Comparison of effects of xenobiotics on extrahepatic and hepatic microsomal drug-metabolizing enzymes in mice. Environ Toxicol Pharmacol. 1996;1(2):123-30doi: 10.1016/1382-6689(95)00018-6.
Huang, R., Okuno, H., Takasu, M., Shiozaki, Y., & Inoue, K. (1996). Comparison of effects of xenobiotics on extrahepatic and hepatic microsomal drug-metabolizing enzymes in mice. Environmental toxicology and pharmacology, 1(2), 123-30. https://doi.org/10.1016/1382-6689(95)00018-6
Huang, R, et al. "Comparison of effects of xenobiotics on extrahepatic and hepatic microsomal drug-metabolizing enzymes in mice." Environmental toxicology and pharmacology vol. 1,2 (1996): 123-30. doi: https://doi.org/10.1016/1382-6689(95)00018-6
Huang R, Okuno H, Takasu M, Shiozaki Y, Inoue K. Comparison of effects of xenobiotics on extrahepatic and hepatic microsomal drug-metabolizing enzymes in mice. Environ Toxicol Pharmacol. 1996 Apr 15;1(2):123-30. doi: 10.1016/1382-6689(95)00018-6. PMID: 21781672.
Copy Download .nbib Format: NLM
Share it on

Environ Toxicol Pharmacol. 1996 Apr 15;1(2):123-30. doi: 10.1016/1382-6689(95)00018-6.

Comparison of effects of xenobiotics on extrahepatic and hepatic microsomal drug-metabolizing enzymes in mice.

Environmental toxicology and pharmacology

R Huang, H Okuno, M Takasu, Y Shiozaki, K Inoue

Affiliations

  1. Third Department of Internal Medicine, Kansai Medical University, Funizono-cho, Moriguchi, Osaka 570, Japan.

PMID: 21781672 DOI: 10.1016/1382-6689(95)00018-6

Abstract

The content of microsomal protein is the same in both kidneys and small intestine, corresponding to 57% of the control value expressed as 100% in the untreated liver. The contents of P450 and cytochrome b(5), and the activity of NADPH-cytochrome c reductase in the kidney were higher than those in the small intestine, which were 17%, 22% and 41% of controls, respectively, in the former and 5%, 11% and 22% of controls in the latter. As compared with similar measurements made in the liver, the activities of substrate-metabolizing enzymes in these extrahepatic organs were very low. The activities of renal aniline hydroxylase, aminopyrine N-demethylase, 7-ethoxycoumarin O-deethylase, 7-methoxycoumarin O-demethylase and benzo(a)pyrene hydroxylase were 6%, 5%, 3%, 0.6% and 0.2% of controls, respectively. The activities of these enzymes in the small intestine were lower than those in the kidney or below the limits of detection. These results suggested that isoforms or their contents of P450 responsible for these substrate biotransformations are different among liver, kidneys and small intestine. Meantime, this study showed similar significant inductions by phenobarbital and rifampin of small intestinal and hepatic microsomal drug-metabolizing enzymes. In contrast, neither phenobarbital nor rifampin was capable of increasing renal microsomal enzymes, with the exception of benzo(a)pyrene hydroxylase which was induced by rifampin. These findings indicated that both liver and small intestine, but not kidneys contain the same phenobarbital- and rifampin-inducible P450 isoforms, cytochrome b(5) and NADPH-cytochrome c reductase. In addition, CCl(4) could be bioactivated by CYP2E1 to free radicals in the kidney which caused destruction of microsomal enzymes. In mice pretreated with phenobarbital, CCl(4) also attenuated the increase in content of P450 in the small intestine, which appeared to be a result of induction by phenobarbital of CYP2E1.

Publication Types